Cargando…

Efficacy and Safety of Treatments for Patients With Portal Hypertension and Cirrhosis: A Systematic Review and Bayesian Network Meta-Analysis

Background and Aims: Viral hepatitis are one of the main causes of liver cirrhosis. The treatment of portal hypertension caused by liver cirrhosis is difficult and diverse, and the therapeutic effect is unknown. Bayesian network meta-analysis was performed to compare the efficacy and safety of treat...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yao, Qigu, Chen, Wenyi, Yan, Cuilin, Yu, Jiong, Jiang, Tian'an, Cao, Hongcui
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2021
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8446274/ https://www.ncbi.nlm.nih.gov/pubmed/34540867 http://dx.doi.org/10.3389/fmed.2021.712918

Ejemplares similares

Stem cell therapy for Crohn’s disease: systematic review and meta-analysis of preclinical and clinical studies
por: Wang , Ruo, et al.
Publicado: (2021)

Contrast-enhanced ultrasonography for the management of portal hypertension in cirrhosis
por: Maruyama, Hitoshi, et al.
Publicado: (2022)

Efficacy and Safety of PD-1/PD-L1 Checkpoint Inhibitors versus Anti-PD-1/PD-L1 Combined with Other Therapies for Tumors: A Systematic Review
por: Zhang, Yiru, et al.
Publicado: (2023)

Efficacy and safety of combination PD‐1/PD‐L1 checkpoint inhibitors for malignant solid tumours: A systematic review
por: Yao, Qigu, et al.
Publicado: (2020)

Highly Efficient Methods to Culture Mouse Cholangiocytes and Small Intestine Organoids
por: Chen, Wenyi, et al.
Publicado: (2022)

Pathophysiology and management of liver cirrhosis: from portal hypertension to acute-on-chronic liver failure
por: Jagdish, Rakesh Kumar, et al.
Publicado: (2023)

Editorial: Portal hypertension in cirrhosis and liver vascular diseases: from ethiopathogenesis to current strategies
por: Luo, Xuefeng, et al.
Publicado: (2023)

The Association of Helicobacter pylori With Portal Hypertensive Gastropathy in Patients With and Without Cirrhosis
por: Noor, ., et al.
Publicado: (2022)

A Nomogram for Predicting Portal Hypertensive Gastropathy in Patients With Liver Cirrhosis: A Retrospective Analysis
por: Wang, WenSheng, et al.
Publicado: (2022)

The kidney in cirrhosis with portal hypertension
por: Olteanu, D, et al.
Publicado: (2010)

The Clinical Efficacy and Safety of Stem Cell Therapy for Diabetes Mellitus: A Systematic Review and Meta-Analysis
por: Zhang, Yazhen, et al.
Publicado: (2020)

Comparative efficacy of treatment strategies for hepatocellular carcinoma: systematic review and network meta-analysis
por: Tian, Guo, et al.
Publicado: (2018)

Pooled Analysis of Mesenchymal Stromal Cell-Derived Extracellular Vesicle Therapy for Liver Disease in Preclinical Models
por: Fang, Xinru, et al.
Publicado: (2023)

Hematological Indices in Portal Hypertension: Cirrhosis versus Noncirrhotic Portal Hypertension
por: Sahin, Abdurrahman, et al.
Publicado: (2018)

Carvedilol for portal hypertension in cirrhosis: systematic review with meta-analysis
por: Li, Tong, et al.
Publicado: (2016)

Portal vein thrombosis in cirrhosis: A literature review
por: Prakash, Swathi, et al.
Publicado: (2023)

Plasma Cyclic Guanosine Monophosphate Is a Promising Biomarker of Clinically Significant Portal Hypertension in Patients With Liver Cirrhosis
por: Sturm, Lukas, et al.
Publicado: (2022)

Hemodynamic alterations in cirrhosis and portal hypertension
por: Kim, Moon Young, et al.
Publicado: (2010)

Advances and challenges in cirrhosis and portal hypertension
por: Berzigotti, Annalisa
Publicado: (2017)

Diagnostic and Prognostic Roles of Thrombospondin-2 in Digestive System Cancers
por: Gao, Feiqiong, et al.
Publicado: (2022)

Relationship between hemodynamic parameters and portal venous pressure in cirrhosis patients with portal hypertension
por: Yao, Hongjuan, et al.
Publicado: (2020)

Computed Tomography-Based Texture Features for the Risk Stratification of Portal Hypertension and Prediction of Survival in Patients With Cirrhosis: A Preliminary Study
por: Wan, Shang, et al.
Publicado: (2022)

Mesenchymal stem cells protect against ferroptosis via exosome-mediated stabilization of SLC7A11 in acute liver injury
por: Lin, Feiyan, et al.
Publicado: (2022)

Human Placental Mesenchymal Stem Cells Relieve Primary Sclerosing Cholangitis via Upregulation of TGR5 in Mdr2(−/−) Mice and Human Intrahepatic Cholangiocyte Organoid Models
por: Yao, Qigu, et al.
Publicado: (2023)

Surveillance for portal hypertension in the course of liver cirrhosis
por: Piekarska, Anna, et al.
Publicado: (2018)

Managing portal hypertension in patients with liver cirrhosis
por: Sauerbruch, Tilman, et al.
Publicado: (2018)

Extrapulmonary Sarcoidosis Manifested as Cirrhosis with Portal Hypertension
por: Kothakota, Sunil Raviraj, et al.
Publicado: (2021)

Portal hypertension in cirrhosis: Pathophysiological mechanisms and therapy
por: Iwakiri, Yasuko, et al.
Publicado: (2021)

The effect of carvedilol and propranolol on portal hypertension in patients with cirrhosis: a meta-analysis
por: Chen, Sheng, et al.
Publicado: (2015)

A Narrative Review on Non-Cirrohotic Portal Hypertension: Not All Portal Hypertensions Mean Cirrhosis
por: Fiordaliso, Michele, et al.
Publicado: (2023)

Efficacy and Safety of Treatment With Ferric Carboxymaltose in Patients With Cirrhosis and Gastrointestinal Bleeding
por: Ballester-Clau, Raquel, et al.
Publicado: (2020)

The Impact of Portal Vein Thrombosis on the Prognosis of Patients With Cirrhosis: A Retrospective Propensity-Score Matched Study
por: Chen, Zhiji, et al.
Publicado: (2021)

Diagnostic efficacy of noninvasive liver fibrosis indexes in predicting portal hypertension in patients with cirrhosis
por: Wang, Le, et al.
Publicado: (2017)

Portal Hypertensive Polyps as Gastroscopic Finding in Liver Cirrhosis
por: Topal, Firdevs, et al.
Publicado: (2020)

Pulmonary hypertension in patients with hepatic cirrhosis and portal hypertension. An echographic study
por: GURGHEAN, ADRIANA V., et al.
Publicado: (2017)

Association of ACEi/ARB Use and Clinical Outcomes of COVID-19 Patients With Hypertension
por: Ma, Jing, et al.
Publicado: (2021)

A Meta-analysis of the Value of vWF in the Diagnosis of Liver Cirrhosis with Portal Hypertension
por: Ding, Xiang-Chun, et al.
Publicado: (2018)

Prognostic Value of Serum Exosomal AHCY Expression in Hepatitis B-Induced Liver Cirrhosis
por: Tong, Ling, et al.
Publicado: (2021)

The efficacy and safety of eravacycline compared with current clinically common antibiotics in the treatment of adults with complicated intra-abdominal infections: A Bayesian network meta-analysis
por: Meng, Rui, et al.
Publicado: (2022)

Future therapy of portal hypertension in liver cirrhosis – a guess
por: Sauerbruch, Tilman, et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_a5ti1ea323p40qa8eshn8pqco9